Media
Articles & insights
14 May 2025
The professors behind the ColdZyme studies interviewed by BioStock
8 May 2025
CEO Claus Egstrand presented Enzymatica at Redeyes theme day on Medtech.
5 May 2025
Interview with CEO Claus Egstrand on Q12025 by BioStock
1 April 2025
ColdZyme’s independent study highlighted in Läkartidningen’s ‘New Findings’ section.
14 March 2025
Replay of the Press Conference on ColdZyme, March 5, 2025
11 March 2025
Enzymatica’s results published in The Journal of Physiology
11 November 2024
Enzymatica - Providing Answers to Questions
13 September 2024
Pro cyclist Charlotte Hodgkins-Byrne shares how ColdZyme boosts her success
12 September 2024
Biostock on the reported final study results: ColdZyme shortens the duration of illness and relieves symptoms
2 July 2024